Collaborative Stage

Note 1: The Follicular Lymphoma Prognostic Index (FLIPI) has been developed for follicular lymphomas and predicts outcome based on the following adverse factors:
    Age greater than or equal to 60 years
    Ann Arbor Stage III or IV
    More than 4 nodal areas involved
    Elevated serum lactate dehydrogenase LDH level
    Serum hemoglobin concentration less than 12 grams/deciliter (g/dl)
Note 2: Record the FLIPI as documented in the medical record. Do not calculate points or assign risk. Only record points or risk if a physician has documented them. Use points over risk if both are available.
Note 3: There are now three indices/scores associated with lymphoma: The International Prognostic Index (IPI, CS Site-Specific Factor 3), the Follicular Lymphoma International Prognostic Index (FLIPI, CS Site-Specific Factor 4) and the International Prognostic Score (IPS) (for Hodgkin lymphomas, CS Site-Specific Factor 5.) Physicians may use these indices/scores interchangeably. For coding:
    Score identified: Value in appropriate CS SSF, 999 in other two CS SSF
    Score not identified, point value 5 or less: 999 in all three CS SSF
    Score not identified, point value 6or 7: Value in CS SSF 5 (IPS), 999 in other two CS SSF

Code	Description
000	0 points
001	1 point
002	2 points
003	3 points
004	4 points
005	5 points
888	OBSOLETE DATA CONVERTED V0200 See code 988 Not applicable for this schema
988	Not applicable: Information not collected for this case (May include cases converted from code 888 used in CSv1 for "Not applicable" or when the item was not collected. If this item is required to derive T, N, M, or any stage, use of code 988 may result in an error.)
990	Stated as low risk (0-1 point)
991	Stated as intermediate risk (2 points)
992	Stated as high risk (3-5 points)
999	Unknown or no information Not documented in patient record

CS Site-Specific Factor 4Follicular Lymphoma Prognostic Index (FLIPI)